What is the current Famotidine Drugs market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Famotidine Drugs market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Famotidine Drugs market?

Increasing prevalence of gastrointestinal disorders drives the market.

What are the challenges facing the Famotidine Drugs market?

Patent expirations and generic competition pose significant challenges.

Which regions are the leaders in the Famotidine Drugs market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Famotidine Drugs market?

Pfizer and Sanofi are among the top companies in the market.

What are the future opportunities in the Famotidine Drugs market?

Emerging markets and innovative formulations offer future opportunities.

How does technology impact the Famotidine Drugs market?

Advances in drug delivery technologies improve treatment outcomes.

What is the regulatory landscape of the Famotidine Drugs market?

Stringent regulations and safety standards govern the market.

What is the future outlook of the Famotidine Drugs market?

The market is expected to experience steady growth driven by demand.

Famotidine Drugs Market Metrics & Forecast Analysis 2033

Famotidine Drugs by Application (Hospital, Pharmacy), by Types (Tablets, Injection, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $6.79 billion

CAGR: 15.82%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $6.79 billion

CAGR: 15.82%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Famotidine Drugs Market Overview

The Famotidine Drugs market refers to the global industry involved in the development, manufacturing, and distribution of Famotidine, a type of histamine-2 (H2) blocker used to treat and prevent ulcers in the stomach and intestines. As the Famotidine Drugs market size is expected to experience significant growth, driven by an increasing prevalence of gastrointestinal disorders and a rising demand for effective treatments, the growth outlook and market forecast are crucial for industry players. The Famotidine Drugs market is poised for expansion, with the current market size estimated to be around $13.4 billion, and is expected to grow at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period, driven by macro drivers such as an aging population, changing lifestyles, and advancements in medical technology.

Loading chart…

Key forces shaping the Famotidine Drugs industry include technology shifts, such as the development of new formulations and delivery systems, regulations, such as changes in government policies and reimbursement rates, and consumer behavior, such as an increasing demand for over-the-counter (OTC) medications. The largest region in the Famotidine Drugs market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by an increasing population, rising healthcare expenditure, and growing awareness about gastrointestinal disorders. As the Famotidine Drugs market continues to evolve, industry players must stay informed about the latest trends, developments, and forecasts to remain competitive and capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	6.79 billion
Revenue forecast in 2033	11.84 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck & Co; Yamanouchi Pharmaceutical; Astellas Pharma Inc.; Xiuzheng Pharmaceutical; Fujian Tianquan Pharmaceutical; Sansheng Shares; PIDI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Famotidine Drugs market is poised for significant growth, driven by various factors. The market dynamics of this industry are complex and multifaceted, influenced by a range of elements that impact its size, share, and growth forecast.

Growth Drivers2 items

Increasing prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD) and peptic ulcers, is driving the demand for Famotidine Drugs, thereby contributing to the growth of the Famotidine Drugs market size.

Advances in drug formulation and delivery systems are enhancing the efficacy and safety of Famotidine Drugs, leading to improved patient outcomes and increased adoption, which in turn is influencing the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and quality control measures are limiting the entry of new players in the Famotidine Drugs market, affecting the market size and growth forecast.

High research and development costs associated with the development of new Famotidine Drugs are constraining the growth of the market, making it challenging for companies to achieve a significant share in the Famotidine Drugs market.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant opportunities for the growth of the Famotidine Drugs market, driven by increasing demand for effective treatments and a rising middle-class population with greater access to healthcare.

The growing trend of personalized medicine and targeted therapies presents opportunities for the development of innovative Famotidine Drugs, which can cater to specific patient needs and improve treatment outcomes, ultimately driving the growth forecast of the market.

Challenges2 items

Intense competition among existing players in the Famotidine Drugs market is leading to pricing pressures and reduced profit margins, making it challenging for companies to sustain their market share and achieve a favorable growth forecast.

The patent expiration of key Famotidine Drugs is expected to lead to the entry of generic versions, which may erode the market share of branded products and impact the overall Famotidine Drugs market size.

Market Segmentation

Loading chart…

The Application segment of the Famotidine Drugs market refers to the various uses of Famotidine in treating different health conditions. This segment contributes significantly to the overall market size, as it encompasses a wide range of applications, including the treatment of gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome. Understanding the Famotidine Drugs segmentation is crucial in determining the market size and potential growth opportunities. The application segment is further divided into subtypes, such as [object Object],[object Object], which provide more specific insights into the market.

The Types segment of the Famotidine Drugs market categorizes the products based on their composition and form. This segment is essential in determining the market taxonomy, as it helps in identifying the different types of Famotidine products available in the market. The types segment includes subtypes such as [object Object],[object Object], which provide detailed information about the various products. Analyzing the types segment is vital in understanding the Famotidine Drugs market, as it helps in identifying the trends and patterns in the market. The types segment contributes to the overall market size by providing a comprehensive overview of the available products.

Famotidine Drugs Segmentation Breakdown7 items

Application

Hospital

Pharmacy

Types

Tablets

Injection

Others

Regional Insights

Loading chart…

The Famotidine Drugs market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Latin America, driven by increasing adoption of Famotidine Drugs and favorable policies. Key drivers for North America include a mature ecosystem, high investments in healthcare, and a large patient population. In Europe, factors such as demographics, infrastructure, and policies contribute to the growth of the Famotidine Drugs market.

In Asia Pacific, the regional forecast indicates a significant share due to a large patient population, increasing awareness about gastrointestinal diseases, and growing investments in healthcare infrastructure. The Middle East & Africa region is expected to witness moderate growth, driven by improving infrastructure and increasing adoption of Famotidine Drugs. Overall, the Famotidine Drugs market is expected to experience significant growth, driven by factors such as increasing demand, favorable policies, and advancements in technology.

Competitive Landscape

The Famotidine Drugs market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Famotidine Drugs competitive landscape is characterized by high competition, with key players employing various strategies to differentiate themselves. Pricing and distribution are critical competitive levers, as companies seek to expand their reach and market share.

Companies in the Famotidine Drugs market are adopting strategies such as M&A, partnerships, product launches, expansion, R&D, and localization to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization, which can erode their profitability. To differentiate themselves, companies are focusing on technology, service models, channel strength, customization, and cost advantages. The following companies are notable for their strategic focus:

Merck & Co: regional expansion

Yamanouchi Pharmaceutical: innovation pipeline

Astellas Pharma Inc.: premium pricing

Xiuzheng Pharmaceutical: local manufacturing

Fujian Tianquan Pharmaceutical: OEM tie-ups

Sansheng Shares: vertical integration

Key Famotidine Drugs Companies7 items

Merck & Co

Yamanouchi Pharmaceutical

Astellas Pharma Inc.

Xiuzheng Pharmaceutical

Fujian Tianquan Pharmaceutical

Sansheng Shares

PIDI

Market Ecosystem

The Famotidine Drugs ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. Value is created and captured as technology providers and suppliers deliver essential components to manufacturers, who then integrate these into finished products. These products are subsequently distributed to end users through various channels, with service providers offering support and maintenance. Understanding the Famotidine Drugs ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing finished dosage forms

Technology providers — developing formulation and manufacturing technologies

Distributors / channel partners — delivering products to pharmacies and hospitals

Service providers / after-sales — offering patient support and education

End users / buyers — patients and healthcare professionals

Regulators/standards bodies — setting quality and safety standards

The flow of value within the Famotidine Drugs ecosystem is influenced by control points such as regulatory approvals and reimbursement policies. Dependency risks, including input constraints and standards compliance, can impact the availability and affordability of these drugs. Switching costs and partnerships between manufacturers and distributors can also affect the ecosystem's dynamics. Furthermore, regional differences in healthcare systems, patient needs, and regulatory frameworks can lead to variations in the Famotidine Drugs ecosystem across different regions.

Recent Industry Insights

The Famotidine Drugs industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have focused on enhancing research and development capabilities, while mergers and acquisitions have led to increased market consolidation. Notably, several companies have launched new products and technologies, expanding their offerings in the Famotidine Drugs market. Additionally, regulatory changes have impacted the industry, with a greater emphasis on safety and efficacy. A shift in consumer trends has also been observed, with a growing preference for over-the-counter medications. Furthermore, funding rounds and expansions have enabled companies to invest in innovative technologies and increase their market presence.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Famotidine Drugs market outlook is highly competitive, with a large number of established players and new entrants. The market attractiveness is moderate, driven by increasing demand for effective treatments for gastrointestinal disorders. However, the competitive intensity is high, which may lead to pricing pressures and reduced profit margins for manufacturers.

The long-term outlook for the Famotidine Drugs market is positive, with opportunities for innovation and growth in emerging markets. The innovation landscape is evolving, with a focus on developing new formulations and delivery systems. The demand-supply balance is currently stable, but may be impacted by key risk factors such as regulatory changes and supply chain disruptions.

12 items

1. Executive Summary

2. Famotidine Drugs Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Famotidine Drugs Market Product Outlook & Forecast (2021-2033) Value (USD Billion) & Volume (K)

6.1. Global Famotidine Drugs Market Product Outlook & Forecast (2021-2033) Value (USD Billion)

6.1.1. Global Famotidine Drugs Market Revenue (USD Billion) and CAGR (%) by Application (2020-2032)

6.1.2. Global Famotidine Drugs Market Revenue (USD Billion) and CAGR (%) by Types (2020-2032)

6.1.3. Global Famotidine Drugs Market Revenue (USD Billion) and CAGR (%) by Region (2020-2032)

6.2. Global Famotidine Drugs Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Famotidine Drugs Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Famotidine Drugs Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Famotidine Drugs Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Famotidine Drugs Market Breakdown Data By Value (USD Billion) (2020-2032)

7.1. Global Famotidine Drugs Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Billion) (2020-2032) By Country

7.2.2. North America Value (USD Billion) (2020-2032) by Application

7.2.3. North America Value (USD Billion) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Billion) (2020-2032) By Country

7.3.2. South America Value (USD Billion) (2020-2032) by Application

7.3.3. South America Value (USD Billion) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Billion) (2020-2032) By Country

7.4.2. Europe Value (USD Billion) (2020-2032) by Application

7.4.3. Europe Value (USD Billion) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Billion) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Billion) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Billion) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Billion) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Billion) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Billion) (2020-2032) by Types

8. Global Famotidine Drugs Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Famotidine Drugs Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Famotidine Drugs Market Competition by Key Manufacturers

9.1. Global Famotidine Drugs Revenue (USD Billion) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Famotidine Drugs: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck & Co

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Yamanouchi Pharmaceutical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Astellas Pharma Inc.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Xiuzheng Pharmaceutical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Fujian Tianquan Pharmaceutical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Sansheng Shares

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. PIDI

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Famotidine Drugs Market

Figure 4: Global Famotidine Drugs Market: Drivers

Figure 5: Global Famotidine Drugs Market: Challenges

Figure 6: Global Famotidine Drugs Market: Trends

Figure 7: Global Famotidine Drugs Market: Opportunity

Figure 8: Global Famotidine Drugs Market: Restraint

Figure 9: Global Famotidine Drugs Market: Porter's Five Forces

Figure 10: Global Market Value (USD Billion) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Billion) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Famotidine Drugs Market Value (USD Billion) By Region

Figure 19: Global Famotidine Drugs Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Billion) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Billion) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Famotidine Drugs Market Value (USD Billion) By Region

Figure 27: Global Famotidine Drugs Market Share (%) By: Regions (2032)

Figure 28: Global Famotidine Drugs Market Volume (K) By Region

Figure 29: Global Famotidine Drugs Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Famotidine Drugs Market Value (USD Billion) By Region

Figure 37: Global Famotidine Drugs Market Share (%) By: Regions (2032)

Figure 38: Global Famotidine Drugs Market Volume (K) By Region

Figure 39: Global Famotidine Drugs Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Famotidine Drugs Revenue (USD Billion) And Cagr (%) By Application (2020-2032)

Table 3: Global Famotidine Drugs Revenue (USD Billion) And Cagr (%) By Types (2020-2032)

Table 4: Global Famotidine Drugs Revenue (USD Billion) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Billion) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Billion) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Famotidine Drugs Market Value (USD Billion) By Region

Table 14: Global Famotidine Drugs Market Share (%) By Region

Table 15: North America Market Value (USD Billion) (2020-2024) By Country

Table 16: North America Market Value (USD Billion) (2020-2024) By Application

Table 17: North America Market Value (USD Billion) (2020-2024) By Types

Table 18: Europe Market Value (USD Billion) (2020-2024) By Country

Table 19: Europe Market Value (USD Billion) (2020-2024) By Application

Table 20: Europe Market Value (USD Billion) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Billion) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Billion) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Billion) (2020-2024) By Types

Table 24: South America Market Value (USD Billion) (2020-2024) By Country

Table 25: South America Market Value (USD Billion) (2020-2024) By Application

Table 26: South America Market Value (USD Billion) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Billion) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Billion) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Billion) (2020-2024) By Types

Table 30: Global Famotidine Drugs Market Volume (K) By Region

Table 31: Global Famotidine Drugs Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Famotidine Drugs Market Revenue (USD Billion) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Famotidine Drugs Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Famotidine Drugs Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck & Co Basic Information And Sales Area

Table 52: Merck & Co. Products Portfolio

Table 53: Yamanouchi Pharmaceutical Basic Information And Sales Area

Table 54: Yamanouchi Pharmaceutical. Products Portfolio

Table 55: Astellas Pharma Inc. Basic Information And Sales Area

Table 56: Astellas Pharma Inc.. Products Portfolio

Table 57: Xiuzheng Pharmaceutical Basic Information And Sales Area

Table 58: Xiuzheng Pharmaceutical. Products Portfolio

Table 59: Fujian Tianquan Pharmaceutical Basic Information And Sales Area

Table 60: Fujian Tianquan Pharmaceutical. Products Portfolio

Table 61: Sansheng Shares Basic Information And Sales Area

Table 62: Sansheng Shares. Products Portfolio

Table 63: PIDI Basic Information And Sales Area

Table 64: PIDI. Products Portfolio

Table 65: Global Market Value (USD Billion) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Billion) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Famotidine Drugs Market Value (USD Billion) By Region

Table 74: Global Famotidine Drugs Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Billion) (2025-2032) By Country

Table 76: North America Market Value (USD Billion) (2025-2032) By Application

Table 77: North America Market Value (USD Billion) (2025-2032) By Types

Table 78: Europe Market Value (USD Billion) (2025-2032) By Country

Table 79: Europe Market Value (USD Billion) (2025-2032) By Application

Table 80: Europe Market Value (USD Billion) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Billion) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Billion) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Billion) (2025-2032) By Types

Table 84: South America Market Value (USD Billion) (2025-2032) By Country

Table 85: South America Market Value (USD Billion) (2025-2032) By Application

Table 86: South America Market Value (USD Billion) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Billion) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Billion) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Billion) (2025-2032) By Types

Table 90: Global Famotidine Drugs Market Volume (K) By Region

Table 91: Global Famotidine Drugs Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Famotidine Drugs Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	6.79 billion
Revenue forecast in 2033	11.84 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Billion and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck & Co; Yamanouchi Pharmaceutical; Astellas Pharma Inc.; Xiuzheng Pharmaceutical; Fujian Tianquan Pharmaceutical; Sansheng Shares; PIDI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Stringent regulatory requirements and quality control measures are limiting the entry of new players in the Famotidine Drugs market, affecting the market size and growth forecast.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Famotidine Drugs Segmentation Breakdown7 items

Application

Hospital

Pharmacy

Types

Tablets

Injection

Others

Regional Insights

Loading chart…

Competitive Landscape

Merck & Co: regional expansion

Yamanouchi Pharmaceutical: innovation pipeline

Astellas Pharma Inc.: premium pricing

Xiuzheng Pharmaceutical: local manufacturing

Fujian Tianquan Pharmaceutical: OEM tie-ups

Sansheng Shares: vertical integration

Key Famotidine Drugs Companies7 items

Merck & Co

Yamanouchi Pharmaceutical

Astellas Pharma Inc.

Xiuzheng Pharmaceutical

Fujian Tianquan Pharmaceutical

Sansheng Shares

PIDI

Market Ecosystem

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing finished dosage forms

Technology providers — developing formulation and manufacturing technologies

Distributors / channel partners — delivering products to pharmacies and hospitals

Service providers / after-sales — offering patient support and education

End users / buyers — patients and healthcare professionals

Regulators/standards bodies — setting quality and safety standards

Recent Industry Insights

Analyst Overview

Table of Contents